移植市場規模、佔有率及成長分析（依產品類型、應用、最終用途及地區）－2025-2032 年產業預測

2023 年全球移植市場規模價值為 154.7 億美元，預計將從 2024 年的 168.5 億美元成長到 2032 年的 333.2 億美元，預測期內（2025-2032 年）的複合年成長率為 8.9%。

全球移植市場預計將經歷顯著成長，主要原因是人口老化和生活方式改變導致器官衰竭和慢性病發病率上升。手術技術的改進、免疫抑制療法的進步以及組織工程的創新顯著提高了移植成功率，從而推動了需求。然而，該領域面臨的挑戰包括移植手術的複雜性、對專門護理的需求以及移植前後護理的高成本所帶來的經濟負擔。儘管存在這些障礙，但透過機器灌注器官保存和免疫抑制劑的改進等技術，仍具有市場開發潛力。提高意識和政府齊心協力促進器官捐贈對於解決器官短缺問題、擴大移植服務以及最終改善患者預後至關重要。

目錄

介紹

• 調查目的
• 研究範圍
• 定義

調查方法

• 資訊採購
• 二次資料和一次資料方法
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 細分機會分析

市場動態與展望

• 市場概覽
• 市場規模
• 市場動態
  • 促進因素和機會
  • 限制與挑戰
• 波特的分析

關鍵市場考察

• 關鍵成功因素
• 競爭程度
• 主要投資機會
• 市場生態系統
• 市場吸引力指數（2024年）
• PESTEL分析
• 總體經濟指標
• 價值鏈分析
• 定價分析
• 案例研究
• 監管格局

移植市場規模（按產品類型和複合年成長率） (2025-2032)

• 市場概覽
• 紙巾產品
• 免疫抑制劑
• 儲存解決方案

移植市場規模：按應用和複合年成長率（2025-2032）

• 市場概覽
• 器官移植
• 組織移植

移植市場規模：依最終用途及複合年成長率（2025-2032）

• 市場概覽
• 醫院
• 移植中心
• 其他

移植市場規模及複合年成長率（2025-2032）

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭資訊

• 前五大公司對比
• 主要企業市場定位（2024年）
• 主要市場參與者所採取的策略
• 近期市場趨勢
• 公司市場佔有率分析（2024年）
• 主要企業簡介
  • 公司詳情
  • 產品系列分析
  • 公司分部佔有率分析
  • 收益與前一年同期比較對比（2022-2024 年）

主要企業簡介

• AbbVie Inc.（USA）
• BioLife Solutions（USA）
• Medtronic（USA）
• Arthrex, Inc.（USA）
• Zimmer Biomet（USA）
• 21st Century Medicine（USA）
• Novartis AG（Switzerland）
• Stryker（USA）
• Teva Pharmaceutical Industries Ltd.（Israel）
• Veloxis Pharmaceuticals, Inc.（USA）
• TransMedics Inc.（USA）
• Hoffmann-La Roche Ltd.（Switzerland）
• Astellas Pharma Inc.（Japan）
• Preservation Solutions, Inc.（USA）
• OrganOx Limited（UK）
• Terumo Corporation（Japan）
• Transonic（USA）
• Sanofi（France）
• Pfizer Inc.（USA）
• CareDx, Inc.（USA）

結論和建議

Global Transplantation Market size was valued at USD 15.47 billion in 2023 and is poised to grow from USD 16.85 billion in 2024 to USD 33.32 billion by 2032, growing at a CAGR of 8.9% during the forecast period (2025-2032).

The global transplantation market is poised for significant growth, driven primarily by the rising incidence of organ failure and chronic diseases, fueled by aging populations and lifestyle changes. Enhanced surgical techniques, advanced immunosuppressive therapies, and innovations in tissue engineering have markedly improved transplant success rates, boosting demand. However, the sector faces challenges, including the complexity of transplant procedures, specialized care requirements, and the financial burden associated with high costs of pre- and post-transplant care. Despite these hurdles, the market holds potential for advancement through technology, such as machine perfusion for organ preservation and the development of improved immunosuppressive drugs. Increased awareness and collaborative government efforts to promote organ donation are essential to address shortages and expand transplantation services, ultimately enhancing patient outcomes.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Transplantation market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Transplantation Market Segments Analysis

Global Transplantation Market is segmented by Product Type, Application, End-Use and region. Based on Product Type, the market is segmented into Tissue Products, Immunosuppressive Drugs and Preservation Solutions. Based on Application, the market is segmented into Organ Transplantation and Tissue Transplantation. Based on End-Use, the market is segmented into Hospitals, Transplant Centers and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Transplantation Market

The increasing prevalence of chronic diseases, including end-stage renal failure, liver cirrhosis, heart failure, and respiratory ailments, is driving significant growth in the global transplantation market. Specifically, the surge in diabetes cases and its associated complications has intensified the need for kidney and pancreas transplants. As more individuals require these vital organ transplants to improve their quality of life and overcome debilitating health conditions, the demand for transplantation services continues to rise. This trend highlights the critical role that healthcare providers and organizations play in addressing the urgent need for organ donations and transplantation solutions worldwide.

Restraints in the Global Transplantation Market

The global transplantation market faces several constraints primarily due to the high costs associated with organ transplantation. Expenses encompass pre-transplant evaluations, surgical procedures, post-operative care, and ongoing immunosuppressive medication, creating substantial financial strains for patients, healthcare systems, and insurance providers alike. Additionally, inadequate insurance coverage and restrictive reimbursement policies surrounding transplant-related services further diminish the affordability and accessibility of these essential procedures. As a result, many individuals may struggle to receive necessary transplants, which can significantly hinder the overall growth and development of the transplantation market on a worldwide scale.

Market Trends of the Global Transplantation Market

The global transplantation market is witnessing a notable trend towards precision medicine, reflecting a heightened emphasis on personalized transplant therapies. This approach leverages individual genetic profiles, immunological compatibility, and specific disease characteristics to enhance treatment efficacy. The incorporation of advanced diagnostics and biomarkers facilitates tailored immunosuppressive strategies, leading to improved patient outcomes and reduced complications. As healthcare providers increasingly utilize genetic testing, the demand for customized transplant protocols is expected to rise, driving innovation and fueling market growth. This shift towards precision medicine underscores the commitment to optimize transplantation success rates and enhance quality of life for patients worldwide.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Case Studies
• Regulatory Landscape

Global Transplantation Market Size by Product Type & CAGR (2025-2032)

• Market Overview
• Tissue Products
• Immunosuppressive Drugs
• Preservation Solutions

Global Transplantation Market Size by Application & CAGR (2025-2032)

• Market Overview
• Organ Transplantation
• Tissue Transplantation

Global Transplantation Market Size by End-Use & CAGR (2025-2032)

• Market Overview
• Hospitals
• Transplant Centers
• Others

Global Transplantation Market Size & CAGR (2025-2032)

• North America (Product Type, Application, End-Use)
  • US
  • Canada
• Europe (Product Type, Application, End-Use)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product Type, Application, End-Use)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product Type, Application, End-Use)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product Type, Application, End-Use)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• AbbVie Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BioLife Solutions (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Arthrex, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Zimmer Biomet (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• 21st Century Medicine (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Novartis AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Stryker (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Teva Pharmaceutical Industries Ltd. (Israel)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Veloxis Pharmaceuticals, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• TransMedics Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hoffmann-La Roche Ltd. (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Astellas Pharma Inc. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Preservation Solutions, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• OrganOx Limited (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Terumo Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Transonic (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sanofi (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pfizer Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CareDx, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations